Giorgia Guglielmi
Diet and gut microbes can shape immune cell function and improve responses to anti-cancer therapy.
A gut bacterium, Clostridium steroidoreducens, can chemically modify steroid hormones, including those used to treat IBD.
L. mucosae and L. ruminis can produce serotonin in the gut, where it promotes nerve growth and regulates intestinal motility.
Researchers have found that certain gut bacteria and their metabolites differ between IBS subtypes.
Changes in gut bacteria, especially Akkermansia, could predict treatment success in people with lung cancer.
Ethical, long-term partnerships can uncover valuable scientific insights while respecting Indigenous knowledge.
Controlling cadaverine levels and the gut bacteria that produce it could help regulate immune cell metabolism and inflammation.
Environments and social factors shape human microbiotas.
The abundance of Bifidobacterium may explain M116’s excellent cholesterol profile and low inflammation levels.
The authors propose a coordinated framework involving policymakers, scientists, educators, and communities to embed microbiota science into One Health strategies.
